These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32827712)

  • 1. PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease.
    Ponce-Ruiz N; Murillo-González FE; Rojas-García AE; Barrón-Vivanco BS; Bernal-Hernández YY; González-Arias CA; Ortega-Cervantes L; Ponce-Gallegos J; López-Guarnido O; Medina-Díaz IM
    Exp Gerontol; 2020 Oct; 140():111062. PubMed ID: 32827712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake.
    Ponce-Ruiz N; Murillo-González FE; Rojas-García AE; Bernal Hernández YY; Mackness M; Ponce-Gallegos J; Barrón-Vivanco BS; Hernández-Ochoa I; González-Arias CA; Ortega Cervantes L; Cardoso-Saldaña G; Medina-Díaz IM
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):40-48. PubMed ID: 31757567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers.
    González FEM; Ponce-RuÍz N; Rojas-GarcÍa AE; Bernal-Hernández YY; Mackness M; Ponce-Gallegos J; Cardoso-Saldaña G; Jorge-Galarza E; Torres-Tamayo M; Medina-Díaz IM
    Arch Med Sci Atheroscler Dis; 2019; 4():e47-e54. PubMed ID: 31211270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PON1 lactonase activity and its association with cardiovascular disease.
    Murillo-González FE; Ponce-Ruiz N; Rojas-García AE; Rothenberg SJ; Bernal-Hernández YY; Cerda-Flores RM; Mackness M; Barrón-Vivanco BS; González-Arias CA; Ponce-Gallegos J; Medina-Díaz IM
    Clin Chim Acta; 2020 Jan; 500():47-53. PubMed ID: 31626760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
    Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
    Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
    Bhattacharyya T; Nicholls SJ; Topol EJ; Zhang R; Yang X; Schmitt D; Fu X; Shao M; Brennan DM; Ellis SG; Brennan ML; Allayee H; Lusis AJ; Hazen SL
    JAMA; 2008 Mar; 299(11):1265-76. PubMed ID: 18349088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients.
    Angayarkanni N; Barathi S; Seethalakshmi T; Punitham R; Sivaramakrishna R; Suganeswari G; Tarun S
    Eye (Lond); 2008 Jul; 22(7):969-74. PubMed ID: 18084236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
    Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
    Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired measurement of serum amyloid A (SAA) and paraoxonase 1 (PON1) as useful markers in breast cancer recurrence.
    Bobin-Dubigeon C; Lefrançois A; Classe JM; Joalland MP; Bard JM
    Clin Biochem; 2015 Nov; 48(16-17):1181-3. PubMed ID: 26188919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
    Ochoa-Martínez ÁC; Orta-García ST; Varela-Silva JA; Pérez-Maldonado IN
    Biochem Genet; 2020 Oct; 58(5):801-820. PubMed ID: 32519276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
    Cervellati C; Bonaccorsi G; Trentini A; Valacchi G; Sanz JM; Squerzanti M; Spagnolo M; Massari L; Crivellari I; Greco P; Parladori R; Passaro A; Ricci G
    Scand J Clin Lab Invest; 2018; 78(1-2):18-24. PubMed ID: 29168398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase activity in Greek migrants and Anglo-Celtic persons in the Melbourne Collaborative Cohort Study: relationship to dietary markers.
    Lee CT; Rowley K; Jenkins AJ; O'Dea K; Itsiopoulos C; Stoney RM; Su Q; Giles GG; Best JD
    Eur J Nutr; 2005 Jun; 44(4):223-30. PubMed ID: 15309416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
    Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
    Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 activities and genetic variation in childhood obesity.
    Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
    Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments.
    Moshtaghie E; Nayeri H; Moshtaghie AA; Asgary S
    ARYA Atheroscler; 2022 Mar; 18(2):1-6. PubMed ID: 36819838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
    Imga NN; Topcuoglu C; Berker D; Turhan T
    Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
    Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
    Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
    J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.